Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal

We estimated comparative primary and booster vaccine effectiveness (VE) of SARS-CoV-2 Omicron BA.5 and BA.2 lineages against infection and disease progression. During April–June 2022, we implemented a case–case and cohort study and classified lineages using whole-genome sequencing or spike gene targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kislaya, Irina, Casaca, Pedro, Borges, Vítor, Sousa, Carlos, Ferreira, Bibiana I., Fonte, Ana, Fernandes, Eugénia, Dias, Carlos Matias, Duarte, Sílvia, Almeida, José Pedro, Grenho, Inês, Coelho, Luís, Ferreira, Rita, Ferreira, Patrícia Pita, Borges, Cláudia Medeiros, Isidro, Joana, Pinto, Miguel, Menezes, Luís, Sobral, Daniel, Nunes, Alexandra, Santos, Daniela, Gonçalves, António Maia, Vieira, Luís, Gomes, João Paulo, Leite, Pedro Pinto, Nunes, Baltazar, Machado, Ausenda, Peralta-Santos, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973705/
https://www.ncbi.nlm.nih.gov/pubmed/36737101
http://dx.doi.org/10.3201/eid2903.221367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973705/
https://www.ncbi.nlm.nih.gov/pubmed/36737101
http://dx.doi.org/10.3201/eid2903.221367

Ejemplares similares